NVYT

Novacyt S.A. (NVYTF)

Market Closed
11 Jul, 13:31
OTC PINK OTC PINK
$
0. 55
0
0%
$
56.51M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
$ 0.55
Previous Close
Day Range
0.55 0.55
Year Range
0.5 1.25
Want to track NVYTF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 72 days
Novacyt S.A. (NVYTF) Q4 2024 Earnings Call Transcript

Novacyt S.A. (NVYTF) Q4 2024 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q4 2024 Results Conference Call April 30, 2025 6:00 AM ET Company Participants Lyn Rees - Chief Executive Officer Steve Gibson - Chief Financial Officer Operator Good morning, and welcome to the Novacyt Full Year Results Investor Presentation.

Seekingalpha | 2 months ago
Novacyt S.A. (NVYTF) Q2 2024 Earnings Call Transcript

Novacyt S.A. (NVYTF) Q2 2024 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q2 2024 Earnings Conference Call September 26, 2024 6:00 AM ET Company Participants Lyn Rees - Chief Executive Officer Steve Gibson - Chief Financial Officer Conference Call Participants Good morning and welcome to the Novacyt Investor presentation.

Seekingalpha | 9 months ago
Novacyt shares drop 16% on legal settlement news

Novacyt shares drop 16% on legal settlement news

Novacyt SA's (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) share price fell 16% following the announcement of a commercial settlement in its High Court case. The molecular diagnostics company agreed to pay £5 million to the Department of Health and Social Care, resolving all claims and counterclaims.

Proactiveinvestors | 1 year ago
Novacyt S.A. (NVYTF) Q4 2023 Earnings Call Transcript

Novacyt S.A. (NVYTF) Q4 2023 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q4 2023 Earnings Conference Call May 30, 2024 6:00 AM ET Company Participants Lyn Rees - CEO Steve Gibson - CFO Conference Call Participants Operator [abrupt start] and welcome to the Novacyt Investor Presentation.

Seekingalpha | 1 year ago